SRPT

Sarepta Therapeutics, Inc. News Headlines

$16.17
*  
0.44
2.8%
Get SRPT Alerts
*Delayed - data as of Oct. 31, 2014  -  Find a broker to begin trading SRPT now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
Biotech Stock Mailbag: Prosensa, Sarepta, Arena Pharma, Hemispherx
10/31/2014 6:40:00 AM - TheStreet


5 Stocks To Consider When Playing Ebola
10/29/2014 11:31:00 AM - Seeking Alpha


Sarepta Slumps as Eteplirsen NDA Submission Gets Delayed - Analyst Blog
10/28/2014 2:22:00 PM - Zacks.com


Sarepta Slumps: SRPT Plunges 32.5% in Session - Tale of the Tape
10/28/2014 8:49:00 AM - Zacks.com


Sector Update: Health Care Stocks Little Changed; Sarepta Therapeutics Slammed After FDA Asks for More Data on Eteplirsen Drug Candidate
10/27/2014 1:44:21 PM - MT Newswires


Sector Update: Health Care
10/27/2014 1:41:50 PM - MT Newswires


Midday Update: Stocks FluctuatingToday As Pressure on Energy Sector Offset By Technical Support
10/27/2014 12:40:22 PM - MT Newswires


Why Sarepta Therapeutics Inc Stock Is Crashing Today
10/27/2014 10:31:08 AM - Motley Fool


Sarepta Therapeutics Inc. (SRPT) Has Fallen To An 11-Month Low On FDA News
10/27/2014 9:33:00 AM - RTT News


Ebola Hits NYC: Time To Panic
10/27/2014 8:45:00 AM - Seeking Alpha


Pre-Market Most Active for Oct 27, 2014 : PBR, BSBR, SAN, NOK, PBR/A, CQB, SRPT, MU, QQQ, NVAX, FB, TVIX
10/27/2014 8:38:58 AM - NASDAQ.com News


Why I Won't Buy Ebola Stocks
10/27/2014 8:31:03 AM - Motley Fool


Sarepta Therapeutics Says FDA Seeks Further Data On Eteplirsen
10/27/2014 7:30:00 AM - RTT News


Making Money With Charles Payne: 10/24/14
10/24/2014 6:00:00 PM - Fox Business


Could Sarepta Therapeutics Inc. Be Running Out of Money?
10/24/2014 9:13:07 AM - Motley Fool


Biotech Stock Mailbag: Rockwell Medical, Oxigene, Prosensa, Sarepta
10/24/2014 8:28:00 AM - TheStreet


Should Ebola Fear... Tobacco?
10/19/2014 12:15:02 PM - Motley Fool


Detailed Analysis Of Sarepta's Ebola Virus Cocktail: Full Phase I Clinical Trial Analysis For Non-Scientists
10/18/2014 12:47:00 PM - Seeking Alpha


Stomach-Churning Ride for Ebola Stocks
10/17/2014 2:52:00 PM - Fox Business


Sector Update: Strong Advance for Health Care Sector; Sarepta Therapeutics Up After Positive Results for Possible Ebola Treatment
10/17/2014 1:49:55 PM - MT Newswires


Sector Update: Health Care
10/17/2014 1:47:22 PM - MT Newswires


U.S. Hot Stocks: Hot Stocks to Watch
10/17/2014 9:23:00 AM - Dow Jones Business News


AFFX In Harmony, SRPT, IBIO Focusing On Ebola, PCYC Inks Deal With Roche
10/17/2014 12:53:00 AM - RTT News


Making Money With Charles Payne: 10/16/14
10/16/2014 6:00:00 PM - Fox Business


Prosensa Starts Rolling NDA Submission for Drisapersen - Analyst Blog
10/13/2014 5:30:00 PM - Zacks.com